2017 ANNUAL REPORT
Vision To Prevent and Cure Liver Disease AASLD Mission To advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care. AASLD Foundation Mission To invest in innovative hepatology research and in the people who study and treat liver disease. Contents Treatment Advances & Awareness... 1 Professional Development... 2 Organizational Health... 3 AASLD Membership Growth... 3 FY2017 Combined Financial Position... 4 FY2017 Combined Net Assets... 4 FY2017 Combined Revenue & Expenses... 5 FY2017 Combined Revenue... 5 FY2017 Combined Expenses... 6 AASLD 2017 Governing Board... 6 AASLD Foundation 2017 Board of Trustees... 7 In Remembrance... 7
Treatment Advances & Awareness Clinical Practice Guidelines Guidelines for the Treatment of Chronic Hepatitis (Includes 3 Systematic Reviews) Released January 2017 Global Outreach & Engagement Offered International Travel Awards Exhibited at APASL, EASL and AMH Annual Meetings Jointly provided global programs with AMH, APASL, ALEH, EASL and SASLT Provided Joint Symposium with EASL and Global Forum at The Liver Meeting 2017 Provided Sponsorship for the following programs: Gordon Research Conference; Network of Minority Health Research Investigators 15th Anniversary Annual Meeting; International HBV Meeting; 24th Annual International HCV Conference; Hepatobiliary Cancers: Pathobiology and Translational Advances; World Hepatitis Summit Endorsed programs of: TASL; FDA/ CPATH; Chinese Society of Hepatology; INASL; Hellenic Association for the Study of the Liver AASLD 2017 ANNUAL REPORT 1
9,500 + Registrants 2,268 Accepted Abstracts 3,643+ Postgraduate Course Attendance 2,967+ Basic Science Symposium Professional Development? Emerging Trends Conference Emerging Trends in NAFLD 384 Participants Clinical Hepatology Update 174 Participants STC: Acute on Chronic Liver Failure Is it Ready for Clinical Practice? 67 Participants AASLD Webinars Eight New Webinars in 2017 618 Registrants 2 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES
Organizational Health AASLD Membership Growth Ensuring the Future of Hepatology 240 Number of Matches in the New Mentorship Program 32% Amount AASLD Membership has grown since 2012 61 New AASLD Fellows (562 Total) 29 New Emerging Liver Scholars (166 since 2012) MOC Committee AASLD Membership Growth 6000 5000 4731 4978 5313 4733 Corporate Affiliate Emeritus 4000 3597 3683 4129 Associate International Trainee* Trainee International Fellow 3000 Fellow International 2000 Regular 1000 *This reflects a change in the membership year to July 1 June 30 0 2011 2012 2013 2014 2015 2016 2017* AASLD 2017 ANNUAL REPORT 3
FY2017 Combined Financial Position 60 $16 50 40 $13 Foundation AASLD Millions 30 20 $44 $36 10 $3 $8 0 Assets $60M Liabilities $11M Net Assets $49M FY2017 Combined Net Assets 8% 10% Permanently Restricted $4,061,850 Temporarily Restricted $4,942,921 67% 15% Unrestricted Board Designated $7,231,413 Unrestricted Undesignated $32,731,794 4 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES
FY2017 Combined Revenue & Expenses Revenue $17,627,832 Income from Investments $4,951,657 Expenses -$18,535,802 Surplus $4,043,687 For full financial statements refer to aasld.org FY2017 Combined Revenue 1% 0% 9% 6% Annual Meeting ($8.4M) Research Grants & Contributions ($3.6M) 16% 48% Publications, AASLD Journals & enews ($2.8M) Membership Dues & Mailing List Income ($1.5M) Meetings & Education ($1.1M) 20% Professional Relations ($117K) Rental Income ($90K) AASLD 2017 ANNUAL REPORT 5
FY2017 Combined Expenses 14% 1% 1% 4% 21% Annual Meeting ($3.9M) Research & Fellowship Awards ($3.8M) Publications, AASLD Journals & enews ($2.2M) Membership and Mentorship ($942K) 2% Meetings & Education ($2.4M) 7% 13% 20% Professional Relations & Public Awareness ($1.2M) Clinical & Public Policies ($392K) Leadership, IT, F&A ($2.6M) Fundraising ($253K) 5% 12% Marketing & Communications ($714K) Fundamentals of Liver Disease ($131K) AASLD & AASLD Foundation spends 85% on Programs service functions and 15% on leadership, administration and fundraising. AASLD 2017 Governing Board President Anna SF Lok, University of Michigan Ann Arbor, MI President-Elect Ronald J. Sokol, University of Colorado Hospital School of Medicine Aurora, CO Secretary Kimberly Ann Brown, Henry Ford Health System Detroit, MI Treasurer Bruce A. Luxon, MD, PhD, FAASLD Georgetown University Hospital Washington, DC Past-President Keith D. Lindor, Arizona State University Phoenix, AZ Councilors Jorge A. Bezerra, Cincinnati Children s Hospital Medical Center Cincinnati, OH Raymond T. Chung, Massachusetts General Hospital Boston, MA Michael W. Fried, University of North Carolina Chapel Hill, NC Councilors- At-Large Mark J. Czaja, Emory University School of Medicine Atlanta, GA Julie Heimbach, MD, FAASLD Mayo Clinic Rochester Rochester, MN Lopa Mishra, MD, FAASLD George Washington University Washington, DC CEO (Ex-Officio) Steven Echard, IOM, CAE Alexandria, VA 6 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES
AASLD Foundation 2017 Board of Trustees Chair Bruce R. Bacon, Saint Louis University St. Louis, MO Vice Chair Ronald J. Sokol, University of Colorado Aurora, CO Treasurer Bruce A. Luxon, MD, PhD, FAASLD Georgetown University Washington, DC Trustees Meena B. Bansal, MD Mount Sinai School of Medicine New York, NY Jorge A. Bezerra, University of Cincinnati Cincinnati, OH Steven L. Flamm, MD Northwestern University Health System Chicago, IL Michael W Fried, University of North Carolina at Chapel Hill Chapel Hill, NC Arun J. Sanyal, Virginia Commonwealth University Richmond, VA In Remembrance John A. Balint, MD Bennett L. Blitzer, MD Lawrence Lumeng, MD John F. Mullane, MD, PhD Ralph M. Myerson, MD Irvin H. Strub, MD Thomas E. Starzl, MD, PhD, FAASLD Juan Rodés, MD Lina Popper AASLD 2017 ANNUAL REPORT 7
AASLD is the professional home for the innovators, educators, and clinicians in hepatology. 1001 North Fairfax Street, 4 th Floor Alexandria, VA 22314 Phone: 703-299-9766 Fax: 703-299-9622 www.aasld.org